Cargando…

A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) are at risk of developing cardiac arrhythmias and elevated heart rate. A theoretical mechanistic association based on the interaction of long-acting β(2)-agonists (LABAs) with adrenoreceptors in the heart and vasculature is assum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andreas, Stefan, Bothner, Ulrich, de la Hoz, Alberto, Kloer, Isabel, Trampisch, Matthias, Alter, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428408/ https://www.ncbi.nlm.nih.gov/pubmed/32848381 http://dx.doi.org/10.2147/COPD.S246353

Ejemplares similares

No Influence on Cardiac Arrhythmia or Heart Rate from Long-Term Treatment with Tiotropium/Olodaterol versus Monocomponents by Holter ECG Analysis in Patients with Moderate-to-Very-Severe COPD
por: Andreas, Stefan, et al.
Publicado: (2020)

Long-term safety of tiotropium/olodaterol in older patients with moderate-to-very-severe COPD in the TONADO® studies
por: Ferguson, Gary T., et al.
Publicado: (2020)

Long-term safety of tiotropium/olodaterol Respimat(®) in patients with moderate-to-very severe COPD and renal impairment in the TONADO(®) studies
por: LaForce, Craig, et al.
Publicado: (2018)

Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD
por: Andreas, Stefan, et al.
Publicado: (2020)

Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat(®) device for maintenance treatment of COPD: comparison with the long-acting β(2)-agonist formoterol
por: Koch, Andrea, et al.
Publicado: (2017)

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
por: Calverley, Peter M, et al.
Publicado: (2016)

Second look Holter ECG in neurorehabilitation
por: Knecht, Stefan, et al.
Publicado: (2019)

Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO(®) Trials
por: Rabe, Klaus F., et al.
Publicado: (2020)

Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO(®) study
por: Minakata, Yoshiaki, et al.
Publicado: (2019)

Tiotropium/Olodaterol: A Review in COPD
por: Blair, Hannah A.
Publicado: (2019)

Heritability of ECG Biomarkers in the Netherlands Twin Registry Measured from Holter ECGs
por: Hodkinson, Emily C., et al.
Publicado: (2016)

Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO(®) study [Erratum]
Publicado: (2019)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study
por: Ichinose, Masakazu, et al.
Publicado: (2018)

Correction to: Tiotropium/Olodaterol: A Review in COPD
por: Blair, Hannah A.
Publicado: (2019)

Efficacy of tiotropium–olodaterol fixed-dose combination in COPD
por: Derom, Eric, et al.
Publicado: (2016)

Usefulness of measurement of heart rate variability by holter ECG in hemodialysis patients
por: Kida, Nanami, et al.
Publicado: (2017)

QRS detection and classification in Holter ECG data in one inference step
por: Ivora, Adam, et al.
Publicado: (2022)

Intermittent short ECG recording is more effective than 24-hour Holter ECG in detection of arrhythmias
por: Hendrikx, Tijn, et al.
Publicado: (2014)

Software‐based analysis of 1‐hour Holter ECG to select for prolonged ECG monitoring after stroke
por: Gröschel, Sonja, et al.
Publicado: (2020)

ECG monitoring of post-stroke occurring arrhythmias: an observational study using 7-day Holter ECG
por: Carrarini, Claudia, et al.
Publicado: (2022)

Cardiac safety of tiotropium in patients with COPD: a combined analysis of Holter-ECG data from four randomised clinical trials
por: Hohlfeld, J M, et al.
Publicado: (2015)

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD
por: Pelaia, Girolamo, et al.
Publicado: (2015)

Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database
por: Quint, Jennifer K., et al.
Publicado: (2021)

Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO(®) and OTEMTO(®) Studies
por: Buhl, Roland, et al.
Publicado: (2020)

The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPD
por: Herth, Felix, et al.
Publicado: (2020)

Daily ECG transmission versus serial 6-day Holter ECG for the assessment of efficacy of ablation for atrial fibrillation — the AGNES-ECG study
por: Sikorska, Agnieszka, et al.
Publicado: (2022)

Independent Component Analysis and Decision Trees for ECG Holter Recording De-Noising
por: Kuzilek, Jakub, et al.
Publicado: (2014)

Holter ECG for Syncope Evaluation in the Internal Medicine Department—Choosing the Right Patients
por: Freund, Ophir, et al.
Publicado: (2022)

Assessment of the atrial fibrillation burden in Holter ECG recordings using artificial intelligence
por: Hennings, E, et al.
Publicado: (2023)

Effects of Tiotropium/Olodaterol on Activity-Related Breathlessness, Exercise Endurance and Physical Activity in Patients with COPD: Narrative Review with Meta-/Pooled Analyses
por: Maltais, François, et al.
Publicado: (2020)

Nuclear HSP90 and HSP70 in COPD patients treated with formoterol or formoterol and corticosteroids
por: Holownia, A, et al.
Publicado: (2009)

Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD
por: O'Donnell, Denis E., et al.
Publicado: (2017)

Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells
por: Yang, Nan, et al.
Publicado: (2021)

Budesonide–formoterol (inhalation powder) in the treatment of COPD
por: Ceylan, Erkan
Publicado: (2006)

Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021)

Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD
por: Hanania, Nicola A, et al.
Publicado: (2018)

Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
por: Alcázar Navarrete, Bernardino, et al.
Publicado: (2018)

QT dispersion on ECG Holter monitoring and risk of ventricular arrhythmias in patients with dilated cardiomyopathy
por: DE MARIA, ELIA, et al.
Publicado: (2006)

Obstructive Sleep Apnea as a Predictor of Arrhythmias in 24-h ECG Holter Monitoring
por: Urbanik, Dominika, et al.
Publicado: (2021)

Severe OSA Leading to Long Pauses in 24-h Holter ECG Reversed with CPAP
por: Mukhopadhyay, Mainak, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n9i6s6lrhvjthc85qa2lp5okj9